fh-006
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2024 (NCT06735144)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07241767 | Phase 2 | Nov 12, 2025 | Hengrui Therapeutics, Inc. |
| NCT07136142 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2025 | Hengrui Therapeutics, Inc. |
| NCT06735144 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2024 | Hengrui Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 3 | 3 | 1 | 2024 |
1 organizations
Page 1 / 1